Download in electronic PDF format for $35



Search the Complete Journal Archives

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report

Author(s):  Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don

Issue:  Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Abstract:  The ancient autoimmune skin condition psoriasis is still ubiquitous worldwide, produces the same, often-intolerable effects noted in its earliest recorded descriptions, and remains without cure. Management options designed to resolve the itchy, scaly, weeping, erythematous, and often widespread lesions of that disorder are now available, but they vary in efficacy, most are associated with the development of severe adverse effects, and many are prohibitively expensive. In this article, we describe the successful use of a compounded formulation of oral low-dose naltrexone to manage guttate psoriasis in a 75-year-old white male patient. That therapy produced only 1 adverse effect (dry skin near the lesions on the patient’s arms and legs) and was relatively inexpensive. The formulation for that preparation and comments from the patient, the pharmacist who suggested its use, the prescriber, and the compounder who prepared it are included. Many clinicians are unaware of the benefits of compounded low-dose naltrexone in treating autoimmune diseases. We hope that this case report will encourage compounding pharmacists to consider and suggest it as an alternative therapy for patients who cannot tolerate or afford manufactured medications to treat psoriasis.

Related Keywords: George Muller, RPh, Robert Grieshaber, MD, J. Floyd Talley, RPh, Mike Riepl, RPh, Don Fellows, RPh, autoimmune disorders, skin disorders, guttate psoriasis, inflammation, case report, low-dose naltrexone, formulation, naltrexone hydrochloride, drug costs, adverse effects

Related Categories: DERMATOLOGY, FORMULATIONS, CASE REPORTS, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don Jul/Aug 2018 270-278 Buy
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Ploesser Jennifer, Weinstock Leonard B, Thomas Erin Mar/Apr 2010 171-173 Buy
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn Sep/Oct 2009 386-389 Buy
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Sturn Kayla M, Collin Michael May/Jun 2016 197-201 Buy
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III May/Jun 2010 182-192 Buy
PostScription: Case Reports and Formulations, George Roentsch, RPh. Roentsch George Mar/Apr 2001 160 Buy
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea May/Jun 2017 205-211 Buy
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP Bottoni Don J Jan/Feb 2004 22 Buy
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane Nov/Dec 2008 498-504 Buy
PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP Karolchyk Scott Jan/Feb 2012 4 View Sample